Breyanzi Kit
Product Images NDC 73153-900

12 FDA label images from Juno Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Breyanzi (NDC 73153-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Juno Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Breyanzi 01)

Image (Breyanzi 01)
An instructional diagram showing the process of inverting a vial from an upright to an inverted position. Two vial illustrations are connected by circular arrows indicating the motion from upright to inverted orientation.*
FDA Label Image

Image (Breyanzi 02)

Image (Breyanzi 02)
An instructional illustration showing a pair of gloved hands handling a syringe and a small card or label. The image likely demonstrates a step in preparing or verifying a dose from the BREYANZI cellular therapy kit.*
FDA Label Image

Image (Breyanzi 03)

Image (Breyanzi 03)
An illustration showing a close-up view of a hand holding or interacting with a small cylindrical object or device tip. The image focuses on the contact point between the hand/finger and the device, highlighting the detail of the object tip within a circular frame.*
FDA Label Image

Image (Breyanzi 04)

Image (Breyanzi 04)
An instructional diagram showing how to cut a glass ampule correctly. The image depicts an ampule with a marked cutting line labeled 'CUT HERE' above a 'Filter' area, with a check mark indicating the correct cutting position and an X mark showing an incorrect area to cut.*
FDA Label Image

Image (Breyanzi 05)

Image (Breyanzi 05)
An instructional diagram showing two ampoules with their tops aligned for cutting using scissors, emphasizing safe ampoule opening technique. The illustration is simple with clear outlines, highlighting the cutting point on the ampoule necks.*
FDA Label Image

Image (Breyanzi 06)

Image (Breyanzi 06)
An instructional illustration showing a gloved hand handling a syringe and a vial or syringe barrel with measurement markings. The images depict steps for attaching or detaching the syringe or plunger, indicated by arrows, as part of the preparation or administration process for BREYANZI (Lisocabtagene maraleucel) cellular therapy kit.*
FDA Label Image

Image (Breyanzi 07)

Image (Breyanzi 07)
An instructional illustration showing a hand holding a syringe with the needle capped, and another hand holding a vial or connector below the syringe. The image depicts the step of connecting or preparing a syringe for injection, likely related to the administration of BREYANZI cellular therapy kit.*
FDA Label Image

Image (Breyanzi 08)

Image (Breyanzi 08)
An instructional illustration showing two gloved hands preparing a syringe. One hand holds a small vial or ampule, while the other hand holds the syringe, indicating the process of drawing medication or solution from the vial into the syringe.*
FDA Label Image

Image (Breyanzi 09)

Image (Breyanzi 09)
An instructional illustration showing a gloved hand holding a swab above a rectangular container labeled with a biohazard symbol. The container has a lid and appears to be used for biohazardous material disposal or specimen collection.*
FDA Label Image

Image (Breyanzi 10)

Image (Breyanzi 10)
An instructional diagram showing a pair of gloved hands handling a vial and attaching or removing a label or tag. This image is likely part of preparation or handling steps for the BREYANZI (Lisocabtagene maraleucel) cellular therapy kit.*
FDA Label Image

Fig_transform_graph (Fig Transform Graph)

Fig_transform_graph (Fig Transform Graph)
A Kaplan-Meier survival curve chart comparing event-free survival probabilities over time (in months) from randomization for BREYANZI and standard therapy. The vertical axis shows event-free survival probability, and the horizontal axis shows time up to 19 months. The number of patients at risk for both BREYANZI and standard therapy is listed below the time axis at various intervals.*
FDA Label Image

Fig_kit_carton (Carton Only)

Fig_kit_carton (Carton Only)
Packaging label for BREYANZI (Lisocabtagene maraleucel) cellular therapy kit by Juno Therapeutics, Inc. The label includes detailed product information such as dosage form, usage instructions, storage conditions, and patient identification verification. The design features a blue gradient background with the product name and important warnings clearly displayed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.